Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory study of Cernos injection in transgender men
jRCTs061250028Recruiting
- Start
- Apr 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial of testosterone undecanoate in Gender incongruence (GI). Primary endpoints: Primary: Change in patient-reported satisfaction and masculinization symptoms at 12 months and Primary: Acne, facial hair, scalp hair, and mood changes. Started Apr 2026; status: recruiting.
02
Drugs
testosterone undecanoate
03
Conditions
Gender incongruence (GI)
Beyond the preview
Go deeper on jRCTs061250028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061250028.